INMiND Office
European Institute for Molecular Imaging (EIMI) Waldeyerstr. 15 48149 Münster
Tel.: +49 251 83 49300
Fax: +49 251 83 49313

Metanavigation: 


WELCOME TO INMiND

Imaging of Neuroinflammation in Neurodegenerative Diseases


The goal of INMiND is to identify novel biological targets of neuroinflammation for both diagnostic and therapeutic purposes and to translate this knowledge into clinical application and patient benefit. This aim will be achieved through carrying out collaborative research on molecular mechanisms that link neuroinflammation with neurodegeneration.


Latest Publications

Elsevier 90

Imaging of Neuroinflammation in Alzheimer's Disease, Multiple Sclerosis and Stroke: Recent Developments in Positron Emission Tomography.

[2015-11-28] Janssen B, Vugts DJ, Funke U, Molenaar GT, Kruijer PS, van Berckel BN, Lammertsma AA, Windhorst AD.
Biochim Biophys Acta. 2015 Nov 28 [epub ahead of print]. more …

Royal Society Of Chemistry_

GdDOTAGA(C18)2: an efficient amphiphilic Gd(iii) chelate for the preparation of self-assembled high relaxivity MRI nanoprobes.

[2015-11-26] Filippi M, Remotti D, Botta M, Terreno E, Tei L. Chem Commun (Camb). 2015 Nov 26;51(98):17455-8. more …

Elsevier 90

High-content analysis of α-synuclein aggregation and cell death in a cellular model of Parkinson's disease.

[2015-11-24] Macchi F, Deleersnijder A, Van den Haute C, Munck S, Pottel H, Michiels A, Debyser Z, Gerard M, Baekelandt V. J Neurosci Methods. 2015 Nov 24[epub ahead of print]. more …

RSS-Feed
More Latest Publications


Latest News

Inmind Am2016 90

INMiND consortium met for the fourth time to discuss key achievements

[2016-02-26] For the fourth time the INMiND consortium came together to discuss the key developments the project achieved in questing the dynamics of microglia activation and its contribution to neuronal degeneration and regeneration by molecular imaging technologies in vivo under various paradigms including immunomodulation. more …

Aigner-ludwig-p03 90x90

Rejuvenation of the aged brain and recovery of cognitive functions by an already marketed anti-astmatic drug.

[2015-10-21] New research published in the Journal Nature Communications shows that Montelukast, an already marketed anti-asthmatic drug, reverts brain aging and loss of cognitive functions in old rodents that have received this drug for 6 weeks at dosages fully compatible with those currently used in patients. more …

Logo Consortia Pedia 90x90

Just released! INMiND profile included in the FasterCures' Consortia-pedia Catalogue.

[2015-10-21] INMiND is excited to be part of the recently launched Consortia-pedia Catalogue, a free, online catalogue of medical research consortia. Give it a try and check out INMiND's Consortia-pedia profile. more …

RSS-Feed
More News


CONTACT

INMiND Office
Register now for an INMiND training course!
INMiND at a glance!
This collaborative project is funded by the Seventh Framework Programme of the European Union

Imprint | © 2016
INMiND Office
European Institute for Molecular Imaging (EIMI) Waldeyerstr. 15
· 48149 Münster
Tel.: +49 251 83 49300 · Fax: +49 251 83 49313
E-Mail: